Rhonda Farnum - 01 Dec 2021 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: SVP, Comm & Medical Affairs
Signature: Brett A. Grimaud, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 01 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 10 Dec 2021, 17:34:14 UTC
Next filing: 16 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TBPH	Ordinary Shares						319,951	01 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TBPH	Share Option (Right to Buy)							01 Dec 2021	Ordinary Shares	150,000	$25.64	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested and became exercisable on August 1, 2019, then 1/48th of the shares subject to the option vest became exercisable each month thereafter. The Option shall be fully vested and exercisable on August 1, 2022 provided optionee has remained in continuous service through such date.